Udemy Inc (UDMY – Research Report) received a Hold rating and price target from William Blair analyst Stephen Sheldon yesterday. The ...
4d
Fintel on MSNWilliam Blair Downgrades Udemy (UDMY)Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Udemy (NasdaqGS:UDMY) from Outperform to ...
William Blair downgraded shares of Udemy (NASDAQ:UDMY – Free Report) from an outperform rating to a market perform rating in ...
Udemy Inc (UDMY – Research Report) received a Hold rating and price target from William Blair analyst Stephen Sheldon today. The company’s ...
JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on ...
(Bloomberg) -- JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on private equity firms and sovereign wealth funds. Kallop is ...
Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.
Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.
William Blair currently has a “Neutral” rating and a $14.00 price target on the stock. The consensus estimate for Intellia Therapeutics’ current full-year earnings is ($5.07) per share. Get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results